Project Grant R01DK131488

Award Date 8/1/22
Completion Date 5/31/27
Dollars Obligated $2.9M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
This Project Grant award of $782,916 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research by Dignify Therapeutics, LLC to develop a therapy for fecal incontinence and fecal urgency. The key focus is to inhibit sensitized colorectal afferent terminals using proprietary intrarectal compounds to safely and effectively prevent or reduce symptoms of fecal incontinence, fecal urgency,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $862,002 to The Medical College of Wisconsin, Inc. to conduct an in-depth investigation of mechanisms for enhancing the motor function of fecal continence muscles to improve fecal incontinence in patients. The key objectives are to: 1) characterize the fatigability of continence muscles across adult age groups and...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $215,250 to the Veterans Medical Research Foundation of San Diego to conduct research on preventing anal sphincter dysfunction after childbirth-related neuromuscular injury. The key objectives of the research are to evaluate the efficacy of a novel brain-derived neurotrophic factor (BDNF) sustained-release...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,516,765 to the University of California, Los Angeles (UCLA) to develop and validate an innovative near-infrared spectroscopy (NIRS) technology for the quantitative assessment of pelvic floor muscle function in patients with myofascial pelvic pain (MPP). The research aims to establish NIRS as an effective, non-invasive,...
This federal Project Grant award of $690,451 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to investigate the role of fibroblasts in bladder mucosal function. The key research objectives are to: Determine if suburothelial fibroblast (SUF)-mediated contraction of the lamina propria-associated collagen matrix promotes the reformation of bladder rugae after voiding, and if SUF...
This $384,558 Project Grant award from the National Institutes of Health's (NIH) Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development and evaluation of the "SenseWand" - a wireless pelvic floor diagnostic system (device and app) to assess pelvic floor muscle health using Electrical Impedance Myography (EIM). The recipient, Bold Type LLC, is a minority-owned, small disadvantaged business developing innovative medical devices and...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $316,102 to Mayo Clinic to conduct a pilot, randomized, double-blind, placebo-controlled clinical trial. The trial aims to evaluate the efficacy and safety of proteolytic activity-guided fecal microbiota transplantation (FMT) for improving symptoms in patients with...
This National Science Foundation (NSF) Project Grant, awarded under the Computer and Information Science and Engineering (CISE) program (CFDA 47.070), provides $168,690 to the Florida Institute of Technology Inc. (Florida TECH) to develop a theragnostic (therapeutic + diagnostic) system for inflammatory bowel diseases (IBD). The project aims to model the complex interplay of host, microbial, and environmental factors that trigger IBD using data science, and then leverage synthetic biology and...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a wireless, battery-free bioelectronic implant for closed-loop neuromodulation to manage detrusor sphincter dyssynergia (DSD) in spinal cord injury (SCI) patients. The $206,132 award to the University of Houston System will fund the fabrication and validation...
The University of Connecticut received a $1,941,591 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) to develop an objective integrated multimodal electrophysiological (OIME) index that quantifies the level of visceral pain in patients with irritable bowel syndrome (IBS). The key products/services to be delivered under this 5-year award include: Establishing the OIME index...

PATHOPHYSIOLOGY, DIAGNOSIS AND BIOFEEDBACK THERAPY IN FECAL INCONTINENCE USING FECOBIONICS - ABSTRACT FECAL INCONTINENCE (FI) AFFECTS 1 IN 7 AMERICANS WITH A RISING INCIDENCE THAT POSES A MAJOR HEALTHCARE BURDEN. ITS PATHOPHYSIOLOGY IS POORLY UNDERSTOOD AND CONSEQUENTLY THERE IS DEARTH OF EFFECTIVE TREATMENT(S). A CRITICAL BARRIER TO PROGRESS HAS BEEN THE LACK OF COMPREHENSIVE, PHYSIOLOGICALLY-RELEVANT AND PRACTICAL DIAGNOSTIC TEST FOR IDENTIFYING THE UNDERLYING MECHANISM(S). CURRENT TESTS PROVIDE EITHER INCOMPLETE OR CONFLICTING INFORMATION THAT DO NOT CORRELATE WITH SYMPTOMS AND TREATMENT OUTCOMES. OUR GOAL IS TO DETERMINE THE ROLE OF ANORECTAL MUSCLES IN MAINTAINING CONTINENCE AND FACILITATING DEFECATION, AND HOW ANORECTAL MALFUNCTIONS CAN CAUSE FI BY USING A NOVEL TECHNOLOGY CALLED FECOBIONICS (AN ELECTRONIC SIMULATED STOOL) TO EVALUATE ITS DIAGNOSTIC AND THERAPEUTIC UTILITY. FECOBIONICS HAS THE CONSISTENCY AND SHAPE OF NORMAL STOOL THAT CAN RECORD PRESSURES, CROSS- SECTIONAL AREA, ORIENTATION, AND VISCOELASTIC PROPERTIES OF THE ANORECTUM. WITH HEAVILY UPGRADED HARDWARE, SOFTWARE AND GRAPHICAL USER INTERFACE, THE NEW FECOBIONICS DEVICE MAP THE GEOMETRIC PROFILES DURING EVACUATION AND RELATE THEM TO SIMULTANEOUS CHANGES IN PRESSURES (FORCES) AND BENDING. OUR CENTRAL HYPOTHESIS IS THAT THE MOVEMENT OF THE FECOBIONICS DEVICE THROUGH THE ANORECTUM WILL PROVIDE UNKNOWN AND NEW MECHANISTIC INSIGHTS ON ANORECTAL PHYSIOLOGY INCLUDING INTRALUMINAL PRESSURE CHANGES, ANAL MUSCLE LENGTH-TENSION RELATIONS, RESISTANCE GENERATED DURING MOVEMENT OF THE SURROGATE STOOL AND ITS DEFORMABILITY, AS WELL AS DISTENSIBILITY OF THE ANAL SPHINCTERS IN NORMAL SUBJECTS AND FI PATIENTS. THIS MULTIDIMENSIONAL DATA COULD FACILITATE NEW TREATMENTS FOR FI. ACCORDINGLY, OUR SPECIFIC AIMS ARE TO: 1) DETERMINE THE LENGTH-TENSION PROPERTIES OF THE ANAL SPHINCTERS USING FECOBIONICS IN NORMAL SUBJECTS AND FI PATIENTS DURING ANAL DISTENSION AND DURING SIMULATED EVACUATION. 2) ELUCIDATE THE PATHOPHYSIOLOGICAL CHARACTERISTICS AND BIOMECHANICAL PROPERTIES OF INDIVIDUAL MUSCLE COMPONENTS, EXTERNAL, INTERNAL ANAL SPHINCTER AND PUBORECTALIS MUSCLE USING THE FECOBIONICS DEVICE AND COMPARING FI PATIENTS WITH NORMAL SUBJECT CONTROLS; AND 3) EVALUATE THE USE OF FECOBIONICS AS A BIOFEEDBACK TREATMENT (BT) AND MONITORING TOOL IN FI PATIENTS TO DETERMINE THE PREDICTORS FOR TREATMENT SUCCESS, BY PERFORMING A RANDOMIZED CONTROLLED TRIAL OF FECOBIONICS-ASSISTED BIOFEEDBACK THERAPY (FBT) VERSUS CONVENTIONAL OFFICE-BASED BIOFEEDBACK THERAPY (OBT). OUR PROPOSAL SEEKS TO SHIFT CURRENT FI RESEARCH BY TESTING A STOOL SURROGATE FOR PERFORMING BT AS OPPOSED TO A THIN MANOMETRY PROBE AND EXAMINE THE MULTI-DIMENSIONAL PHYSIOLOGIC CHANGES (I.E., PRESSURE, DEFORMABILITY, BIOMECHANICS, VECTORAL AND TOPOGRAPHIC CHANGES) AS WELL AS CLINICAL OUTCOME FOLLOWING BT. THE UNIQUE ASPECT OF OUR PROPOSAL IS TO SIMULATE STOOLING WITH A WIRELESS BIONICS DEVICE AND EXAMINE IN DETAIL THE MECHANISTIC UNDERPINNINGS IN HEALTH AND IN FI PATIENTS. THE IMPACT OF OUR PROJECT IS TO PROVIDE NEW MECHANISTIC UNDERSTANDING OF ANORECTAL FUNCTION AND PATHOPHYSIOLOGY IN FI AND VALIDATE THE CLINICAL UTILITY OF A NOVEL, HIGHLY INTEGRATED DEVICE FOR DIAGNOSTICS AND FACILITATION OF BIOFEEDBACK THERAPY WITH AN UNPRECEDENTED GRAPHICAL FEEDBACK TO THE PATIENT OF MECHANOSENSORY ACTIONS.

Posted 7/25/22, 12:00 AM